Compound details
Girinimbine
| Compound ID | CDAMM02914 |
|---|---|
| Common name | Girinimbine | IUPAC name | 3,3,5-trimethyl-11H-pyrano[3,2-a]carbazole |
| Molecular formula | C18H17NO |
| Retention time | 0.51 |
|---|---|
| Adduct | [2M+H]+ |
| Actual mz | 527.265 | Theoretical mz | 527.269 |
| Error | 7.54 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.5083 |
| Inchi key | GAEQWKVGMHUUKO-UHFFFAOYSA-N |
|---|---|
| Smiles | O1C=2C(C=CC1(C)C)=C3NC=4C=CC=CC4C3=CC2C |
| Superclass | Organoheterocyclic compounds |
| Class | Indoles and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9Y5N1 | HRH3 | Histamine H3 receptor | T64765 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| P04818 | TYMS | Thymidylate synthase (by homology) | T98397 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SwissTargetPrediction |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SwissTargetPrediction |
| P21554 | CNR1 | Cannabinoid receptor 1 (by homology) | T76685 | SwissTargetPrediction |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SwissTargetPrediction |
| Q05586 | GRIN1 | Glutamate NMDA receptor; GRIN1/GRIN2B | T62276 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P07949 | RET | Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET | T60631 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| Q01959 | SLC6A3 | Dopamine transporter | T55959 | SwissTargetPrediction |
| Q14416 | GRM2 | Metabotropic glutamate receptor 2 | T62820 | SwissTargetPrediction |
| P29275 | ADORA2B | Adenosine A2b receptor | T86679 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SwissTargetPrediction |
| P25021 | HRH2 | Histamine H2 receptor | T30985 | SwissTargetPrediction |
| P35367 | HRH1 | Histamine H1 receptor | T77913 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SwissTargetPrediction |
| O00206 | TLR4 | Toll-like receptor 4 (by homology) | T81443 | SEA |
| Q9UM73 | ALK | ALK tyrosine kinase receptor | T56418 | SwissTargetPrediction |
| P13945 | ADRB3 | Beta-3 adrenergic receptor | T51408 | SwissTargetPrediction |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P04626 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | T14597 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P55072 | VCP | Transitional endoplasmic reticulum ATPase | T12646 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q16769 | QPCT | Glutaminyl-peptide cyclotransferase | T46245 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P25105 | PTAFR | Platelet activating factor receptor | T87023 | SwissTargetPrediction |
| O75874 | IDH1 | Isocitrate dehydrogenase [NADP] cytoplasmic | T69563 | SwissTargetPrediction |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P30518 | AVPR2 | Vasopressin V2 receptor (by homology) | T66237 | SwissTargetPrediction |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SwissTargetPrediction |
| P51449 | RORC | Nuclear receptor ROR-gamma | T25307 | SwissTargetPrediction |
| Q9Y5Y4 | PTGDR2 | G protein-coupled receptor 44 | T61722 | SwissTargetPrediction |
| P80365 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | T43721 | SwissTargetPrediction |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SwissTargetPrediction |
| Q99685 | MGLL | Monoglyceride lipase | T18664 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| Q99572 | P2RX7 | P2X purinoceptor 7 | T63414 | SwissTargetPrediction |
| P17948 | FLT1 | Vascular endothelial growth factor receptor 1 | T63966 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P62136 | PPP1CA | Serine/threonine protein phosphatase PP1-alpha catalytic subunit | T59845 | SwissTargetPrediction |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SwissTargetPrediction |
| P09619 | PDGFRB | Platelet-derived growth factor receptor beta | T59102 | SwissTargetPrediction |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | T47101 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P49760 | CLK2 | Dual specificity protein kinase CLK2 | T73725 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| P35398 | RORA | Nuclear receptor ROR-alpha | T43206 | SwissTargetPrediction |
| P08151 | GLI1 | Zinc finger protein GLI1 | T40890 | SEA |
| Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | T23787 | SwissTargetPrediction |
| P30536 | TSPO | Translocator protein (by homology) | T75440 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| Q05469 | LIPE | Hormone sensitive lipase | T55689 | SwissTargetPrediction |
| Q9Y2T6 | GPR55 | G-protein coupled receptor 55 | T87670 | SwissTargetPrediction |
| P29371 | TACR3 | Neurokinin 3 receptor | T29683 | SwissTargetPrediction |
| Q92630 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | T39486 | SwissTargetPrediction |
| P47900 | P2RY1 | Purinergic receptor P2Y1 | T67818 | SwissTargetPrediction |
| P55055 | NR1H2 | LXR-beta | T13714 | SwissTargetPrediction |
| P53582 | METAP1 | Methionine aminopeptidase 1 | T42337 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| Q92753 | RORB | Nuclear receptor ROR-beta | T48812 | SwissTargetPrediction |
| O43781 | DYRK3 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | T97149 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T64765 | DI0392 | Somnolence | [ICD-11: MG42] | Q9Y5N1 | HRH3 |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T98397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04818 | TYMS |
| T98397 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P04818 | TYMS |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T62276 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q05586 | GRIN1 |
| T62276 | DI0182 | HIV-infected patients with tuberculosis | [ICD-11: 1B10-1B14] | Q05586 | GRIN1 |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T60631 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P07949 | RET |
| T60631 | DI0238 | Lung cancer | [ICD-11: 2C25] | P07949 | RET |
| T60631 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P07949 | RET |
| T60631 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P07949 | RET |
| T60631 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P07949 | RET |
| T60631 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P07949 | RET |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T55959 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q01959 | SLC6A3 |
| T55959 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q01959 | SLC6A3 |
| T55959 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q01959 | SLC6A3 |
| T55959 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q01959 | SLC6A3 |
| T55959 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q01959 | SLC6A3 |
| T55959 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q01959 | SLC6A3 |
| T62820 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q14416 | GRM2 |
| T62820 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q14416 | GRM2 |
| T62820 | DI0116 | Dengue fever | [ICD-11: 1D2Z] | Q14416 | GRM2 |
| T62820 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q14416 | GRM2 |
| T62820 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | Q14416 | GRM2 |
| T62820 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | Q14416 | GRM2 |
| T62820 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q14416 | GRM2 |
| T62820 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | Q14416 | GRM2 |
| T62820 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q14416 | GRM2 |
| T86679 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P29275 | ADORA2B |
| T86679 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P29275 | ADORA2B |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T30985 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | P25021 | HRH2 |
| T30985 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P25021 | HRH2 |
| T30985 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P25021 | HRH2 |
| T77913 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P35367 | HRH1 |
| T77913 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P35367 | HRH1 |
| T77913 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P35367 | HRH1 |
| T77913 | DI0099 | Conjunctiva disorder | [ICD-11: 9A60] | P35367 | HRH1 |
| T77913 | DI0105 | Cough | [ICD-11: MD12] | P35367 | HRH1 |
| T77913 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35367 | HRH1 |
| T77913 | DI0136 | Episodic vestibular syndrome | [ICD-11: AB31] | P35367 | HRH1 |
| T77913 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P35367 | HRH1 |
| T77913 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P35367 | HRH1 |
| T77913 | DI0272 | Morning sickness disorder | [ICD-11: SC00] | P35367 | HRH1 |
| T77913 | DI0292 | Nasopharyngitis | [ICD-11: CA00] | P35367 | HRH1 |
| T77913 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35367 | HRH1 |
| T77913 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35367 | HRH1 |
| T77913 | DI0349 | Pruritus | [ICD-11: EC90] | P35367 | HRH1 |
| T77913 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35367 | HRH1 |
| T77913 | DI0388 | Sleep-wake disorder | [ICD-11: 7A00-7B2Z] | P35367 | HRH1 |
| T77913 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P35367 | HRH1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T81443 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | O00206 | TLR4 |
| T81443 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O00206 | TLR4 |
| T81443 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | O00206 | TLR4 |
| T56418 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T56418 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | Q9UM73 | ALK |
| T56418 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T51408 | DI0030 | Angina pectoris | [ICD-11: BA40] | P13945 | ADRB3 |
| T51408 | DI0037 | Asthma | [ICD-11: CA23] | P13945 | ADRB3 |
| T51408 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13945 | ADRB3 |
| T51408 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P13945 | ADRB3 |
| T51408 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P13945 | ADRB3 |
| T51408 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P13945 | ADRB3 |
| T51408 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P13945 | ADRB3 |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T14597 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P04626 | ERBB2 |
| T14597 | DI0238 | Lung cancer | [ICD-11: 2C25] | P04626 | ERBB2 |
| T14597 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P04626 | ERBB2 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T12646 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P55072 | VCP |
| T12646 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P55072 | VCP |
| T12646 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P55072 | VCP |
| T12646 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P55072 | VCP |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T46245 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | Q16769 | QPCT |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T87023 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P25105 | PTAFR |
| T69563 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O75874 | IDH1 |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T66237 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30518 | AVPR2 |
| T66237 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30518 | AVPR2 |
| T66237 | DI0131 | Enuresis | [ICD-11: 6C00] | P30518 | AVPR2 |
| T66237 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P30518 | AVPR2 |
| T66237 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30518 | AVPR2 |
| T66237 | DI0338 | Polyuria | [ICD-11: MF55] | P30518 | AVPR2 |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T25307 | DI0042 | Autoimmune disease | [ICD-11: 4A40-4A45] | P51449 | RORC |
| T25307 | DI0107 | Crohn disease | [ICD-11: DD70] | P51449 | RORC |
| T25307 | DI0238 | Lung cancer | [ICD-11: 2C25] | P51449 | RORC |
| T25307 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P51449 | RORC |
| T25307 | DI0351 | Psoriasis | [ICD-11: EA90] | P51449 | RORC |
| T25307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P51449 | RORC |
| T61722 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q9Y5Y4 | PTGDR2 |
| T43721 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P80365 | HSD11B2 |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T18664 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q99685 | MGLL |
| T18664 | DI0409 | Tic disorder | [ICD-11: 8A05] | Q99685 | MGLL |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T63414 | DI0224 | Joint pain | [ICD-11: ME82] | Q99572 | P2RX7 |
| T63966 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P17948 | FLT1 |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T59845 | DI0268 | Molluscum contagiosum | [ICD-11: 1E76] | P62136 | PPP1CA |
| T59102 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P09619 | PDGFRB |
| T59102 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P09619 | PDGFRB |
| T59102 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09619 | PDGFRB |
| T47101 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11362 | FGFR1 |
| T47101 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P11362 | FGFR1 |
| T47101 | DI0235 | Liver cancer | [ICD-11: 2C12] | P11362 | FGFR1 |
| T47101 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P11362 | FGFR1 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T43206 | DI0235 | Liver cancer | [ICD-11: 2C12] | P35398 | RORA |
| T43206 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P35398 | RORA |
| T23787 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16875 | PFKFB3 |
| T75440 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P30536 | TSPO |
| T75440 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P30536 | TSPO |
| T75440 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P30536 | TSPO |
| T75440 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P30536 | TSPO |
| T75440 | DI0271 | Mood/affect symptom | [ICD-11: MB24] | P30536 | TSPO |
| T75440 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P30536 | TSPO |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T55689 | DI0332 | Pediculosis | [ICD-11: 1G00] | Q05469 | LIPE |
| T87670 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q9Y2T6 | GPR55 |
| T29683 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P29371 | TACR3 |
| T13714 | DI0039 | Atopic eczema | [ICD-11: EA80] | P55055 | NR1H2 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |